Immunic AG | Finanzwire

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Immunic AG

BRIEF

published on 11/26/2024 at 12:35, 25 days 6 hours ago

Immunic, Inc. Set to Participate in December Investor Conference

Investor Conference Immunic, Inc. Vidofludimus Calcium Piper Sandler Small Molecule Therapies
PRESS RELEASE

published on 11/26/2024 at 12:30, 25 days 6 hours ago

Immunic, Inc. to Participate in Investor Conference in December
Immunic, Inc. to Participate in Investor Conference in December. Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing therapies for chronic inflammatory and autoimmune diseases, announces participation in Piper Sandler 36th Annual Healthcare Conference in New York

Investor Conference Biotechnology Immunic Inc. Clinical Pipeline Autoimmune Diseases
BRIEF

published on 11/13/2024 at 12:35, 1 month 8 days ago

Immunic Publishes Phase 1/1b Trial Data of IMU-856 in The Lancet

Clinical Trial Immunic Gastroenterology IMU-856 Celiac Disease
PRESS RELEASE

published on 11/13/2024 at 12:30, 1 month 8 days ago

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology
Immunic announces publication of phase 1/1b clinical trial data of IMU-856 in The Lancet Gastroenterology & Hepatology. Positive results in celiac disease patients. Potential new approach for gastrointestinal diseases

Gastrointestinal Diseases Clinical Trial Immunic IMU-856 Celiac Disease
BRIEF

published on 11/07/2024 at 12:35, 1 month 14 days ago

Immunic, Inc. Reports Q3 2024 Financial Results

Financial Results Vidofludimus Calcium Phase 3 ENSURE Trials Multiple Sclerosis Research Clinical Trial Updates
PRESS RELEASE

published on 11/07/2024 at 12:30, 1 month 14 days ago

Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2024 financial results, positive Phase 3 ENSURE Program interim analysis. Twin Phase 3 ENSURE trials and Phase 2 CALLIPER trial on track. Webcast held on Nov 7. IMUX stock update

Financial Results Immunic Inc. Q3 2024 Phase 3 ENSURE Program IMUX Stock
BRIEF

published on 10/31/2024 at 11:35, 1 month 21 days ago

Immunic, Inc. to Release Q3 2024 Financial Results and Corporate Update

Financial Results Biotechnology Clinical Trials Webcast Immunic
PRESS RELEASE

published on 10/31/2024 at 11:30, 1 month 21 days ago

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Immunic, Inc. (Nasdaq: IMUX) to release Q3 financial results and corporate update on Nov 7, 2024. Webcast at 8:00 am ET. Company developing therapies for inflammatory and autoimmune diseases. Visit www.imux.com for more info

Financial Results Biotechnology Corporate Update Immunic Inc. Clinical Pipeline
BRIEF

published on 10/29/2024 at 11:35, 1 month 23 days ago

Immunic to Participate in Key Conferences Throughout November

Investors Biotechnology Clinical Trials Conférences Immunic
PRESS RELEASE

published on 10/29/2024 at 11:30, 1 month 23 days ago

Immunic to Participate in Industry, Scientific and Investor Conferences in November
Immunic to participate in industry, scientific, and investor conferences in November 2024, presenting data on IMU-856 for celiac disease. Details on events and presentations available on company website

Clinical Trials Conférences Investor Immunic Scientific

1 2 ... 4

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 59 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 59 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 24 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 29 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 59 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 37 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 43 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 11 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE